<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Topamax; Topiramate: epilepsy" /><meta name="IX" content="Topamax; Topiramate: epilepsy" /><title>Topamax®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="36515.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="36515.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=36515.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2055.htm">4 Central nervous system</a> &gt; <a href="3574.htm">4.8 Antiepileptic drugs</a> &gt; <a href="3575.htm">4.8.1 Control of the epilepsies</a> &gt; <a href="89426.htm">Topiramate</a> &gt; <a href="36514.htm">TOPIRAMATE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="89426.htm" title="Previous: Topiramate">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="3598.htm" title="Next: Valproate">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a397012.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Topiramate</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Anticonvulsants 28:12 &gt; Anticonvulsants, Miscellaneous 28:12.92</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/3130-h.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Topiramate</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: T &gt; Interactions of Topiramate</p></div></li></ul><ul><li><h3>British National Formulary (6)</h3></li><li><a href="3566.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">4.7.4.2 Prophylaxis of migraine</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.7 Analgesics &gt; 4.7.4 Antimigraine drugs</p></div></li><li><a href="9805.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Focal seizures with or without secondary generalisation</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptic drugs &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="9808.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Generalised seizures</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptic drugs &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22topiramate%22%22topiramate%22%22topiramate%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>BNF for Children (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/3566.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">4.7.4.2 Prophylaxis of migraine</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.7 Analgesics &gt; 4.7.4 Antimigraine drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/9805.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Focal seizures with or without secondary generalisation</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/9808.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Generalised seizures</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22topiramate%22%22topiramate%22%22topiramate%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1634.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Topiramate</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; T</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0019s0278.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Topiramate</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; T</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/3130-h.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Topiramate</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiepileptics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/09547.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Topiramate</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; T &gt; TO</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D88.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Topiramate</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; T</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c367.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Topiramate</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; T</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_36514">TOPIRAMATE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i285.htm" title="Go to appendix 1">Topiramate</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">see <a title="BNF:monograph-family: Topiramate" href="89426.htm#_89426">notes above</a></p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">avoid abrupt withdrawal; risk of metabolic acidosis; risk of nephrolithiasis—ensure adequate hydration (especially
in strenuous activity or warm environment); avoid in acute
porphyria (<a title="sub-section: Acute porphyrias" href="5181.htm#_5181">section 9.8.2</a>); <b>interactions:</b> see <a title="target-block: Interactions in epilepsy" href="3575.htm#_120547">Interactions</a> in section 4.8.1 and Appendix 1 (<span>topiramate</span>)</p><div class="cAV"><h3>Important</h3> <p>Topiramate has been associated
with acute myopia with secondary angle-closure glaucoma, typically
occurring within 1 month of starting treatment. Choroidal effusions resulting in anterior displacement of the lens
and iris have also been reported. If raised intra-ocular pressure occurs:</p><ul class="cBF"><li><p class="cQ">seek specialist ophthalmological advice;</p></li><li><p class="cQ">use appropriate measures to reduce intra-ocular pressure;</p></li><li><p class="cQ">stop topiramate as rapidly as feasible</p></li></ul></div></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">use with caution in moderate to severe impairment—clearance
may be reduced</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">use with caution if eGFR less than 60 mL/minute/1.73 m<sup>2</sup>—reduced clearance and longer time to steady-state plasma
concentration</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">see <a title="BNF:target-block: Pregnancy and breast-feeding in epilepsy" href="3575.htm#_120546">Pregnancy</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">manufacturer advises avoid—present in milk;
see also <a title="BNF:target-block: breast-feeding control of epilepsy" href="3575.htm#_207526">Breast-feeding</a></p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">nausea, diarrhoea, vomiting, constipation, dyspepsia,
abdominal pain, dry mouth, taste disturbance, gastritis, appetite
changes, dyspnoea, impaired attention, cognitive impairment, movement
disorders, seizures, tremor, malaise, impaired coordination, speech
disorder, drowsiness, dizziness, sleep disturbance, anxiety, confusion,
paraesthesia, aggression, mood changes, depression, agitation, irritability,
nephrolithiasis, urinary disorders, anaemia, arthralgia, muscle spasm,
myalgia, muscular weakness, visual disturbances, nystagmus, tinnitus,
epistaxis, alopecia, rash, pruritus; <i>less commonly</i> pancreatitis, flatulence, abdominal distension, gingival bleeding,
salivation, halitosis, thirst, glossodynia, bradycardia, palpitation,
hypotension, postural hypotension, flushing, altered sense of smell,
peripheral neuropathy, suicidal ideation, psychosis, panic attack,
influenza-like symptoms, sexual dysfunction, urinary calculus, haematuria,
blood disorders (including leucopenia, neutropenia, and thrombocytopenia),
hypokalaemia, metabolic acidosis, dry eye, photophobia, blepharospasm,
increased lacrimation, mydriasis, hearing loss, reduced sweating,
skin discoloration; <i>rarely</i> Raynaud’s syndrome, periorbital
oedema, unilateral blindness, Stevens-Johnson syndrome, abnormal skin
odour, calcinosis; <i>very rarely</i> angle-closure glaucoma; <i>also reported</i> encephalopathy, hyperammonaemia, maculopathy,
toxic epidermal necrolysis</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Monotherapy in epilepsy, initially 25 mg at night for
1 week <i>then</i> increased in steps of 25–50 mg taken
in 2 divided doses at intervals of 1–2 weeks; usual dose 100–200 mg
daily in 2 divided doses, adjusted according to response; max. 500 mg
daily (doses of 1 g daily have been used in refractory epilepsy); <span class="cAK">child</span> 6–18 years, initially 0.5–1 mg/kg (max. 25 mg)
at night for 1 week <i>then</i> increased in steps of 0.5–1 mg/kg
(max. 50 mg) taken in 2 divided doses at intervals of 1–2 weeks; initial
target dose 100 mg daily in 2 divided doses; max. 15 mg/kg (max. 500 mg)
daily</p><p class="cR">Adjunctive therapy in epilepsy, initially 25–50 mg at night
for 1 week <i>then</i> increased in steps of 25–50 mg taken
in 2 divided doses at intervals of 1–2 weeks; usual dose 200–400 mg
daily in 2 divided doses; max. 400 mg daily; <span class="cAK">child</span> 2–18 years, initially 1–3 mg/kg (max. 25 mg) at night for 1 week <i>then</i> increased in steps of 1–3 mg/kg (max. 50 mg) taken
in 2 divided doses at intervals of 1–2 weeks; usual dose 5–9 mg/kg
daily in 2 divided doses; max. 15 mg/kg (max. 400 mg) daily</p><p class="cR">Migraine prophylaxis, <span class="cAK">adult</span> over
18 years, initially 25 mg at night for 1 week <i>then</i> increased in steps of 25 mg at weekly intervals; usual dose 50–100 mg
daily in 2 divided doses; max. 200 mg daily; <span class="cAK">child</span> 16–18 years see <a href="http://www.medicinescomplete.com/mc/bnfc/current/36514.htm" title="BNFC:monograph: TOPIRAMATE"><i>BNF for Children</i></a></p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="213574.htm#_213574" title="Topiramate">Topiramate</a></li><li class="jN" id="_36515" style="margin: 0 0 0 20px;"><h1 class="title">Topamax®<span> (<a href="appendix-112803-J.htm#m401">Janssen</a>)</span> <a href="204285.htm" title="Report adverse reaction(s)"><img class="cK" src="images/blacktri_s.png" alt="Black triangle" /></a> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Tablets</span>, f/c, <span>topiramate</span> 25 mg, net price 60-tab pack = £19.29; 50 mg (light yellow), 60-tab
pack = £31.69; 100 mg (yellow), 60-tab pack = £56.76; 200 mg (salmon),
60-tab pack = £110.23. 
    Label:
    3, 8, counselling, driving (see <a title="target-block: Driving and epilepsy" href="3575.htm#_200951">notes above</a>)</div><div class="cAY"><span class="cAB">Capsules</span> (<i>Sprinkle</i>®), <span>topiramate</span> 15 mg, net price 60-cap pack =
£14.79; 25 mg, 60-cap pack = £22.18; 50 mg, 60-cap pack = £36.45. 
    Label:
    3, 8, counselling, administration, driving (see <a title="target-block: Driving and epilepsy" href="3575.htm#_200951">notes above</a>)<div class="cAQ"><div class="cAV"><h3>Counselling</h3> <p class="cAX">Swallow whole or sprinkle contents
of capsule on soft food and swallow immediately without chewing</p></div></div></div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="89426.htm">Previous: Topiramate</a> | <a class="top" href="36515.htm#">Top</a> | <a accesskey="]" href="3598.htm">Next: Valproate</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>